These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1772976)

  • 1. Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit model.
    Hubbard T; Olivier T; Bacher P; Walenga JM; Galal H; Fareed J; Pifarre R
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):101-3. PubMed ID: 1772976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant hirudin--initial observations in reconstructive microsurgery.
    Narayanan K; Walenga JM; Liang MD; Fareed J
    Haemostasis; 1991; 21 Suppl 1():168-71. PubMed ID: 1894192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model.
    Fu K; Izquierdo R; Walenga JM; Fareed J
    Thromb Res; 1995 Jun; 78(5):421-8. PubMed ID: 7660358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular repair following crush-avulsion type injury with vein grafts: effect of direct inhibitors of thrombin on patency rate.
    Gravvanis AI; Tsoutsos DA; Lykoudis EG; Iconomou TG; Tzivaridou DV; Papalois AE; Patralexis CG; Ioannovich JD
    Microsurgery; 2003; 23(4):402-7; discussion 408-9. PubMed ID: 12942534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental prevention of free flap thrombosis. I: A model of free flap failure.
    Atchabahian A; Masquelet AC
    Microsurgery; 1996; 17(12):710-3. PubMed ID: 9588717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
    Arnljots B; Bergqvist D
    Plast Reconstr Surg; 1995 Apr; 95(5):894-900. PubMed ID: 7708874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries.
    Chen LE; Seaber AV; Korompilias AV; Urbaniak JR
    Microsurgery; 1995; 16(10):661-5. PubMed ID: 8676728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular surgical experimental thrombosis model: rationale and design.
    Kersh RA; Handren J; Hergrueter C; May JW
    Plast Reconstr Surg; 1989 May; 83(5):866-72; discussion 873-4. PubMed ID: 2710836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antithrombotic effects of ticlopidine and aspirin in a microvascular thrombogenic model.
    Basile AP; Fiala TG; Yaremchuk MJ; May JW
    Plast Reconstr Surg; 1995 Jun; 95(7):1258-64. PubMed ID: 7761514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
    Zhang B; Wieslander JB
    Microsurgery; 1996; 17(2):89-96. PubMed ID: 8914063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin exerts an early antithrombotic effect in small arteries and veins following severe trauma.
    Zhang B; Wieslander JB
    Microsurgery; 1992; 13(6):295-8. PubMed ID: 1333564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining long-term vessel patency in microvascular surgery using tissue-type plasminogen activator.
    Romano JE; Biel MA
    Otolaryngol Head Neck Surg; 1991 Sep; 105(3):391-5. PubMed ID: 1945424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.
    Bode C; Hanson SR; Schmedtje JF; Haber E; Mehwald P; Kelly AB; Harker LA; Runge MS
    Circulation; 1997 Feb; 95(4):800-4. PubMed ID: 9054733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desirudin reduces the rate of microvenous thrombosis in a rat model.
    Lewis CM; Deschler DG
    Laryngoscope; 2008 Jul; 118(7):1149-52. PubMed ID: 18401270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
    Krupinski K; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models for evaluating antithrombotic therapies in replantation microsurgery.
    Cooley BC; Gould JS
    Microsurgery; 1987; 8(4):230-3. PubMed ID: 3431418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.